© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Diebold Nixdorf, Incorporated (DBD) shows an Average True Range (ATR) of 2.78 and an Enterprise Value of N/A. Its average trading volume over the past 3 months is 258.14K, indicating liquidity. These fundamental metrics provide insight into DBD's underlying financial health and market activity.
| ATR | 2.78 |
| Enterprise Value | - |
| Avg Vol (3 Months) | 258.14K |
| Avg Vol (10 Days) | 309.96K |
Diebold Nixdorf, Incorporated (DBD) technical indicators as of March 2, 2026: the SMA 20 is 9.75%, SMA 50 at 16.51%, and SMA 200 at 35.61%. The RSI 14 value is 71.58, suggesting its current momentum. These technical analysis signals help assess DBD's price trends and potential future movements.
| SMA 20 | 9.75% |
| SMA 50 | 16.51% |
| SMA 200 | 35.61% |
| RSI 14 | 71.58 |
Diebold Nixdorf, Incorporated (DBD) stock performance overview as of March 2, 2026: The 52-week high is $84.46 (currently -1.62% below), and the 52-week low is $34.88 (currently 138.14% above). Over the past year, DBD's performance is 59.48%, compared to the S&P 500's 12.68% change.
| 52-Week High | 84.46 |
| 52-Week High Chg | -1.62% |
| 52-Week Low | 34.88 |
| 52-Week Low Chg | +138.14% |
| S&P 500 52-Week Chg | 12.68% |
According to market data, Diebold Nixdorf, Incorporated (DBD) stock's recent performance metrics show that over the last month, DBD is 2.68%, with a Year-to-Date (YTD) performance of 1.06%. Over the past year, the stock has seen a 59.48% change. These figures summarize DBD's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 84.46 | 84.46 | 84.46 | 84.46 | 84.46 | 84.46 |
| Low | 77.28 | 68.25 | 63.15 | 54.5 | 34.88 | 63.7 |
| Performance | -0.07% | +2.68% | +22.54% | +16.21% | +59.48% | +1.06% |
According to current financial data, DBD stock's P/E (TTM) ratio is 30.70, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -0.43. Key valuation ratios for DBD, including P/S (0.75), P/B (2.64), and P/FCF (11.66), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | DBD | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | 30.7 | -0.43 | 112.1 | 32.59 |
| P/S (TTM) | 0.75 | 2.1 | 45.24 | 5.98 |
| P/B (TTM) | 2.64 | 13.9 | 37.52 | 4.97 |
| P/FCF (TTM) | 11.66 | 25.4 | -39.41 | 34.65 |